Safety is the biggest concern for the FDA. How effective TPM opioid patches are is very much secondary to them. This means more testing IMO pre and post approval to be able to market the product as a safer alternative.
- Forums
- ASX - By Stock
- AVE
- Ann: FDA meeting provides guidance for TPM/Oxymorphone patch
Ann: FDA meeting provides guidance for TPM/Oxymorphone patch, page-4
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $3.137K | 1.148M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
68 | 104358077 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 25645581 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
68 | 104358077 | 0.002 |
19 | 73250508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 25478912 | 10 |
0.004 | 23890201 | 19 |
0.005 | 34632738 | 17 |
0.006 | 19365067 | 10 |
0.007 | 9365221 | 8 |
Last trade - 15.17pm 03/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online